Anti-inflammatory aspects of Lidocaine: a neglected therapeutic stance for COVID-19.
作者信息
Maab Hira, Mustafa Faryal, Arshad Ali Shajeea
机构信息
Department of Internal Medicine, Dow University of Health Sciences, Karachi 74200, Pakistan.
Department of Internal Medicine, Dow University of Health Sciences, Karachi 74200, Pakistan.
出版信息
Heart Lung. 2020 Nov-Dec;49(6):877-878. doi: 10.1016/j.hrtlng.2020.09.001. Epub 2020 Sep 17.
Abstract
摘要
相似文献
1
Anti-inflammatory aspects of Lidocaine: a neglected therapeutic stance for COVID-19.利多卡因的抗炎作用：一种被忽视的COVID-19治疗策略。
Heart Lung. 2020 Nov-Dec;49(6):877-878. doi: 10.1016/j.hrtlng.2020.09.001. Epub 2020 Sep 17.
2
The use of lidocaine as an anti-inflammatory substance: a systematic review.利多卡因作为一种抗炎物质的应用：一项系统综述。
J Dent. 2009 Feb;37(2):93-7. doi: 10.1016/j.jdent.2008.10.005. Epub 2008 Dec 5.
3
Lidocaine attenuates lipopolysaccharide-induced inflammatory responses and protects against endotoxemia in mice by suppressing HIF1α-induced glycolysis.利多卡因通过抑制 HIF1α 诱导的糖酵解来减轻脂多糖诱导的炎症反应并保护小鼠免受内毒素血症。
Int Immunopharmacol. 2020 Mar;80:106150. doi: 10.1016/j.intimp.2019.106150. Epub 2020 Jan 17.
4
Lidocaine inhibits secretion of IL-8 and IL-1beta and stimulates secretion of IL-1 receptor antagonist by epithelial cells.利多卡因可抑制上皮细胞分泌白细胞介素-8和白细胞介素-1β，并刺激上皮细胞分泌白细胞介素-1受体拮抗剂。
Clin Exp Immunol. 2002 Feb;127(2):226-33. doi: 10.1046/j.1365-2249.2002.01747.x.
5
Noninfiltrative anesthesia for transrectal prostate biopsy: a randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel.经直肠前列腺活检的非浸润性麻醉：比较利多卡因-丙胺卡因乳膏和利多卡因-酮咯酸凝胶的随机前瞻性研究。
Urol Oncol. 2013 Jan;31(1):68-73. doi: 10.1016/j.urolonc.2010.09.004. Epub 2011 Mar 10.
6
Topical ketamine inhibits albumin extravasation in chemical peritonitis in rats.局部应用氯胺酮可抑制大鼠化学性腹膜炎中的白蛋白外渗。
Acta Anaesthesiol Scand. 1995 Feb;39(2):174-8. doi: 10.1111/j.1399-6576.1995.tb04038.x.
7
JMF2-1, a lidocaine derivative acting on airways spasm and lung allergic inflammation in rats.JMF2-1，一种作用于大鼠气道痉挛和肺部过敏性炎症的利多卡因衍生物。
J Allergy Clin Immunol. 2007 Jan;119(1):219-25. doi: 10.1016/j.jaci.2006.08.037. Epub 2006 Oct 13.
8
Lidocaine increases the anti-inflammatory cytokine IL-10 following mechanical ventilation in healthy mice.利多卡因可增加健康小鼠机械通气后的抗炎细胞因子白细胞介素-10。
Acta Anaesthesiol Scand. 2015 Jan;59(1):47-55. doi: 10.1111/aas.12417. Epub 2014 Oct 14.
9
In vivo priming and ex vivo activation of equine neutrophils in black walnut extract-induced equine laminitis is not attenuated by systemic lidocaine administration.在黑胡桃提取物诱导的马属动物蹄叶炎中，全身给予利多卡因并不能减弱马属动物中性粒细胞的体内预激和体外激活。
Vet Immunol Immunopathol. 2010 Nov 15;138(1-2):60-9. doi: 10.1016/j.vetimm.2010.06.016. Epub 2010 Jun 30.
10
Lidocaine: a neglected anticonvulsant?利多卡因：一种被忽视的抗惊厥药？
South Med J. 1979 Dec;72(12):1564-6.
引用本文的文献
1
Lidocaine Affects Collagen Breakdown Without Compromising Cell Viability in Cultured Human Tenocytes: An In Vitro Study.利多卡因影响培养的人肌腱细胞中的胶原蛋白分解而不损害细胞活力：一项体外研究。
Cells. 2025 Jun 27;14(13):988. doi: 10.3390/cells14130988.
2
Changes in the skeletal muscle transcriptome due to the intramuscular administration of lidocaine in wether lambs.去势羔羊肌肉注射利多卡因后骨骼肌转录组的变化
J Anim Sci. 2025 Jan 4;103. doi: 10.1093/jas/skaf116.
3
A case report of an 18-year-old receiving nebulized lidocaine for treatment of COVID-19 cough.一篇关于 18 岁患者使用雾化利多卡因治疗 COVID-19 咳嗽的病例报告。
Heart Lung. 2023 Jan-Feb;57:140-143. doi: 10.1016/j.hrtlng.2022.09.009. Epub 2022 Sep 22.
4
Lidocaine reinforces the anti-inflammatory action of dexamethasone on myeloid and epithelial cells activated by inflammatory cytokines or SARS-CoV-2 infection.利多卡因增强地塞米松对炎症细胞因子或 SARS-CoV-2 感染激活的髓系和上皮细胞的抗炎作用。
Biomed J. 2023 Feb;46(1):81-92. doi: 10.1016/j.bj.2022.07.008. Epub 2022 Aug 7.
5
Molecular mechanisms of lidocaine.利多卡因的分子机制。
Ann Med Surg (Lond). 2021 Aug 17;69:102733. doi: 10.1016/j.amsu.2021.102733. eCollection 2021 Sep.
本文引用的文献
1
Neutrophil extracellular trapping and angiogenesis biomarkers after intravenous or inhalation anaesthesia with or without intravenous lidocaine for breast cancer surgery: a prospective, randomised trial.静脉或吸入麻醉联合或不联合静脉利多卡因用于乳腺癌手术对中性粒细胞胞外诱捕和血管生成生物标志物的影响：一项前瞻性、随机试验。
Br J Anaesth. 2020 Nov;125(5):712-721. doi: 10.1016/j.bja.2020.05.003. Epub 2020 Jun 29.
2
Nebulized Lidocaine in COVID-19, An Hypothesis.雾化利多卡因在新型冠状病毒肺炎中的应用假说
Med Hypotheses. 2020 Nov;144:109947. doi: 10.1016/j.mehy.2020.109947. Epub 2020 Jun 1.
3
COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies.新型冠状病毒肺炎与心律失常：心律失常特征及管理策略的全球视角
J Interv Card Electrophysiol. 2020 Nov;59(2):329-336. doi: 10.1007/s10840-020-00789-9. Epub 2020 Jun 3.
4
An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine.一种用于管理在接受氯喹或羟氯喹联合阿奇霉素治疗的2019冠状病毒病（COVID-19）患者中QT间期延长的算法：静脉注射利多卡因的潜在益处
HeartRhythm Case Rep. 2020 Apr 1;6(5):244-248. doi: 10.1016/j.hrcr.2020.03.016. eCollection 2020 May.
5
Neutrophil extracellular traps in COVID-19.中性粒细胞胞外陷阱在 COVID-19 中的作用。
JCI Insight. 2020 Jun 4;5(11):138999. doi: 10.1172/jci.insight.138999.
6
Targeting potential drivers of COVID-19: Neutrophil extracellular traps.靶向 COVID-19 的潜在驱动因素：中性粒细胞胞外陷阱。
J Exp Med. 2020 Jun 1;217(6). doi: 10.1084/jem.20200652.
7
WHO Declares COVID-19 a Pandemic.世界卫生组织宣布新冠疫情为大流行病。
Acta Biomed. 2020 Mar 19;91(1):157-160. doi: 10.23750/abm.v91i1.9397.
8
Lidocaine during intubation and extubation in patients with coronavirus disease (COVID-19).新型冠状病毒肺炎（COVID-19）患者插管和拔管期间使用利多卡因的情况。
Can J Anaesth. 2020 Jun;67(6):759. doi: 10.1007/s12630-020-01627-2. Epub 2020 Mar 16.
9
Effect of endovenous lidocaine on analgesia and serum cytokines: double-blinded and randomized trial.静脉内利多卡因对镇痛和血清细胞因子的影响：双盲和随机试验。
J Clin Anesth. 2016 Dec;35:70-77. doi: 10.1016/j.jclinane.2016.07.021. Epub 2016 Aug 6.
10
Effect of Lignocaine on IL-6, IL-8, and MCP-1 in Peritoneal Macrophages and Endometriotic Stromal Cells.利多卡因对腹膜巨噬细胞和子宫内膜异位症基质细胞中白细胞介素-6、白细胞介素-8和单核细胞趋化蛋白-1的影响。
Reprod Sci. 2017 Mar;24(3):382-392. doi: 10.1177/1933719116657188. Epub 2016 Jul 28.
Zotero 插件